Corrigendum
Corrigendum to “ Linkage disequilibrium screening for multiple sclerosis implicates JAG1 and POU2AF1 as susceptibility genes in Europeans ”
[J. Neuroimmunol. 179 (2006) 108 – 116]
Maria Ban
a,ah,⁎ , David Booth
a, Robert Heard
a, Graeme Stewart
a, An Goris
b, Koen Vandenbroeck
c, Bénédicte Dubois
b, Mikko Laaksonen
d, Jorma Ilonen
d, Mehdi Alizadeh
e, Gilles Edan
e,
Marie Claude Babron
f, David Brassat
g, Michael Clanet
g, Isabelle Cournu-Rebeix
h, Bertrand Fontaine
h, Gilbert Semana
e, Rene Goedde
i, Jorg Epplen
i, Alexandra Weber
j, Carmen Infante-Duarte
j, Frauke Zipp
j, Cecilia Rajda
k, Krisztina Bencsik
k, László Vécsei
k,
Shirley Heggarty
l,‡, Colin Graham
l, Stanley Hawkins
m, Maria Liguori
n,
Patricia Momigliano-Richiardi
o, Domenico Caputo
p, Luigi M.E. Grimaldi
q, Maurizio Leone
r, Luca Massacesi
s, Clara Milanese
t, Marco Salvetti
u, Giovani Savettieri
v, Maria Trojano
o, Bartosz Bielecki
w, Marcin P. Mycko
w, Krzysztof Selmaj
w, Monica Santos
x, Patricia Maciel
x, Clara Pereira
y, Ana Silva
z, Berta Martins Silva
y, Francesca Coraddu
aa, Maria Giovanna Marrosu
aa, Eva Åkesson
ab, Jan Hillert
ab, Pameli Datta
ac, Annette Oturai
ac, Hanne F. Harbo
ad, Anne Spurkland
ae, Robert Goertsches
af, Pablo Villoslada
af, Mefkure Eraksoy
ag, Anke Hensiek
ah, Alastair Compston
ah,
Efrosini Setakis
ai, Julia Gray
ah, Tai Wai Yeo
ah, Stephen Sawcer
ahaUniversity of Sydney, Institute for Immunology and Allergy Research, Westmead Millennium Institute, Westmead Hospital, NSW 2145, Australia
bLaboratory of Neuroimmunology, Section of Experimental Neurology, Katholieke Universiteit Leuven, Herestraat 49, 3000 Leuven, Belgium
cApplied Genomics Research Group, McClay Research Centre, The Queen's University of Belfast, Northern Ireland, UK
dTurku Immunology Center and Department of Virology, University of Turku, Kiinamyllynkatu 13, FIN 20520, Turku, Finland
eLaboratoire d’Immunologie, Université de Rennes, UPRES EA 3889, IFR 140, Laboratoire d’Immuno-génétique, Etablissement Français du Sang Bretagne, Rennes, France
fINSERM U535, Villejuif, France
gINSERM U563 and Neurology Federation, Centre Hospitalier Régional Universitaire (CHRU) Purpan and Paul Sabatier University, Toulouse, France
hINSERM U546, Pierre & Marie Curie University, Paris6, Neurology Federation, Groupe Hospitalier Pitie-Salpetriere, Paris, 75013 France
iDepartment of Molecular Human Genetics, Ruhr-University, Universitatsstrasse 150, 44780 Bochum, Germany
jInstitute of Neuroimmunology, Charitè University Hospital, 10098 Berlin, Germany
kUniversity of Szeged, Department of Neurology, Semmelweis u. 6, H-6725 Szeged, Hungary
lRegional Genetics Service, Belfast City Hospital, Belfast, UK
mDepartment of Neurology, Royal Victoria Hospital, Belfast, UK
nDipartimento di Scienze Neurologiche e Psichiatriche, Univ. Bari, Italy
oLaboratorio di Genetica Umana, Dipartimento Scienze Mediche, Univ. Piemonte Orientale and I.R.C.A.D., Novara, Italy
pMultiple Sclerosis Centre; Fondazione don C. Gnocchi–IRCCS, Milano, Italy
qU.O. Neurologia, Fondazione Ospedale San Raffaele“G. Giglio”di Cefalù, Italy
rClinica Neurologica, Ospedale“Maggiore della Carità”, Novara, Italy
sDipartimento di Scienze Neurologiche e Psichiatriche, Univ. Firenze, Italy
tMS Center, IRCCS C. Besta, Milano, Italy
uNeurologia e Centro Neurologico Terapia Sperimentale (CENTERS), Ospedale S. Andrea, Univ.“La Sapienza”, Roma, Italy Journal of Neuroimmunology 189 (2007) 175–176
www.elsevier.com/locate/jneuroim
DOI of original article:10.1016/j.jneuroim.2006.06.003.
⁎Corresponding author. University of Cambridge, Department of Clinical Neurosciences, Addenbrooke’s Hospital, Hills Road, Cambridge, CB2 2QQ, UK. Tel.:
+44 1223 217091; fax: +44 1223 336941.
E-mail address:mb531@medschl.cam.ac.uk(M. Ban).
‡ Present Affiliation–QUB Genomics Core Facility, Queens University Belfast, Belfast, UK.
0165-5728/$ - see front matter © 2007 Elsevier B.V. All rights reserved.
doi:10.1016/j.jneuroim.2007.08.003
vDipartimento di Neurologia, Oftalmologia, Otorinolaringoiatria e Psichiatria, Univ. Palermo, Italy
wDepartment of Neurology, Medical University of Lodz, Lodz, Poland, 22 Kopcinskiego St, 90–153 Lodz, Poland
xHealth and Life Sciences Research Institute, Health Sciences School, University of Minho, Gualtar Campus, 4710-057 BRAGA, Portugal
yInstituto Ciências Biomédicas Abel Salazar–Pathology and Molecular Immunology Department University of Porto, Portugal
zNeurology Department, Hospital Geral Santo António-Porto, Portugal
aaDipartimento di Scienze Cardiovascolari e Neurologiche, University of Cagliari, Centro Sclerosi Multipla, Sardinia, Italy
abDepartment of Clinical Neurosciences, Division of Neurology, Karolinska University Hospital - Huddinge, Karolinska Institute, Stockholm, Sweden
acDepartment of Neurology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
adInstitute of Immunology, University of Oslo, Oslo, Norway
aeDepartment of Anatomy, Institute of Basal Medical sciences, University of Oslo, Oslo, Norway
afNeuroimmunology Unit, Hospital Vall d’Hebron, Barcelona, Spain
agUniversity of Istanbul, Istanbul Faculty of Medicine, Department of Neurology, Istanbul, Turkey
ahUniversity of Cambridge, Department of Clinical Neurosciences, Addenbrooke’s Hospital, Hills Road, Cambridge, CB2 2QQ, UK
aiMRC Biostatistics unit, Institute of Public Health, University Forvie site, Cambridge, UK Received 17 January 2006; received in revised form 2 June 2006; accepted 5 June 2006
The author regret that during the publication of the above paper the byline “The Games Collaborative Group authors and their affiliations are listed in Appendix B” was omitted. The authors and their affiliations are shown above.
176 Corrigendum
